Nephrol Dial Transplant (2000) 15: 1977-1985
© 2000 European Renal Association-European Dialysis and Transplant Association
Renal cancer and malformations in relatives of patients with Bardet-Biedl syndrome
1 Molecular Medicine Unit, Institute of Child Health, University College London, London, 2 Division of Molecular and Medical Genetics, United Medical and Dental School, Guy's Hospital, London, 3 Department of Histopathology, Chase Farm Hospitals NHS Trust, The Ridgeway, Enfield, Middlesex, 4 Department of Histopathology, University College London, London, 5 Division of Medical and Molecular Genetics, Department of Paediatrics and Child Health, University of Birmingham, Edgbaston, Birmingham and 6 Nephro-Urology Unit, Institute of Child Health, University College London, London, UK
Background. Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder with five loci identified thus far. The spectrum of disease includes diverse malformations of the kidney and lower urinary tract. The incidence of BBS is approximately 1/100 000 with a predicted heterozygote frequency of 1/160, and it has been suggested that heterozygotes are at increased risk of obesity and hypertension.
Methods. We describe renal disease in relatives of 109 UK BBS patients. Using PCR with fluorescent microsatellite markers we amplified DNA derived from renal tumours of affected parents to determine whether there was loss of heterozygosity at any of four BBS loci and two other gene loci associated with clear cell renal cell carcinoma (CC-RCC).
Results. CC-RCC was diagnosed in three of 180 BBS parents and there was loss of heterozygosity at BBS1 (11q13) in the tumour tissue of one of these subjects. In addition, there was a high incidence of renal agenesis in siblings of BBS patients and two BBS families were identified with apparently dominant inheritance of renal malformations. In one family we were able to demonstrate that renal malformations segregated with the BBS2 locus (16q21).
Conclusions. Since all parents and two-thirds of siblings of BBS patients must be heterozygous for BBS mutations, our observations may implicate BBS genes in the pathogenesis of both renal cancer and malformations, both disorders of precursor cell growth and differentiation. We suggest these observations may have important implications for screening potential BBS carriers for kidney disease and may lead to a greater understanding of the aetiology of renal disease in the general population.
Keywords: Bardet-Biedl syndrome; loss of heterozygosity; renal cell carcinoma; renal malformations
Correspondence and offprint requests to: Dr P. L. Beales, Molecular Medicine Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1 1EH, UK. E-mail: pbeales{at}hgmp.mrc.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. F. Cox, R. M. Hansen, N. Quinn, and A. B. Fulton Retinal Function in Carriers of Bardet-Biedl Syndrome Arch Ophthalmol, June 1, 2003; 121(6): 804 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Izzedine, B. Bodaghi, V. Launay-Vacher, and G. Deray Eye and Kidney: From Clinical Findings to Genetic Explanations J. Am. Soc. Nephrol., February 1, 2003; 14(2): 516 - 529. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Katsanis, J. R. Lupski, and P. L. Beales Exploring the molecular basis of Bardet-Biedl syndrome Hum. Mol. Genet., October 1, 2001; 10(20): 2293 - 2299. [Abstract] [Full Text] [PDF]
|
|